Clinical systematic observation of Kangxin capsule curing vascular dementia of senile kidney deficiency and blood stagnation type

Journal of Ethnopharmacology

Volumn 112, Issue 2, 2007, Pages 350-355

  Liu, Xifei ^a   Du, Jian ^b   Cai, Jing ^b   Liu, Xifeng ^a   Xu, Gelin ^a   Lin, Anji ^c   Teng, Qing ^c  

^a JINLING HOSPITAL   (China)

^b TCM   (China)

^c Xiamen City University   (China)

Author keywords

Kangxin capsule; Kidney deficiency; Vascular dementia

Indexed keywords

ENDOTHELIN; ESTRADIOL; HERBACEOUS AGENT; KANGXIN; SEX HORMONE; TESTOSTERONE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHINESE MEDICINE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; IMMUNITY; MALE; MULTIINFARCT DEMENTIA; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; VALIDITY;

AGED; AGING; CAPSULES; CARDIOVASCULAR AGENTS; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; DEMENTIA, VASCULAR; DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; ENDOTHELINS; FEMALE; GONADAL STEROID HORMONES; HEMATOLOGIC DISEASES; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RENAL INSUFFICIENCY;

EID: 34248595984     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2007.03.019     Document Type: Article

References (17)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder, (DSM-IV). 4th ed. (1994), American Psychiatric Association, Washington, DC
2. Boulanger C., and Luscher T.F. Release of endothelin from the porcine aorta inhibition by Endothelium derived nitric oxide. J. Clin. Invest. 85 (1990) 587
3. Cai J., Du J., Ge Z.H., et al. The effect of Kangxin capsule on nerve growth factor expression in the cortical parietal lobe and hippocampus CA1 zone of vascular dementia model rats. Chin. J. Gerontol. 2 (2005) 157-159
4. Chen J.P., and Lin Y. Dementia Therapeutics (2002), People's Military Medical Press, Beijing p. 139
5. Fu R.J. Diagnosis, sub-type of syndrome differentiation and evaluation criteria of curative effect (discussion draft). Chin. Med. Mag. 2 (1991) 56
6. Hachinski V.C., Iliff L.D., Zilhka E., et al. Cerebral blood flow in dementia. Arch. Neurol. 32 (1975) 632
7. Li C.S., and Tian R.M. Relationship between serious degrees of lesion quality of acute cerebrovascular disease and solubility of blood plasma endothelin-1. Emerg. Iatrol. 7 (1998) 27-29
8. Li D.Y., Jia Z.R., and Shi Y.T. Research of neurolymph and blood plasma CO and content of endothelin of patients with cerebral infarct. Chin. Nerval Med. Mag. 31 (1998) 291
9. -1 ratio of kidney asthenia with blood stasis vascular dementia rat model. Strait Pharm. J. 17 (2005) 37-41
10. Liu X.F., Du J., Cai J., et al. The study on decoction of Kangxin capsule and its minor components are influenced on peripheral blood CD3, CD4, and CD3/CD4 of the kidney weakness with blood obstruction style vascular dementia rat model. Strait Pharm. J. 16 (2004) 46-51
11. Shen Z.Y. Research of Kidney (Sequel) (1990), Shanghai Science and Technology Press, Shanghai pp. 224-240
12. Wang J., Chen K.Y., and Weng W.L. Diagnostic criteria of blood stagnation disease. Mag. Comb. Tradition. Chin. Med. West. Med. 8 (1988) 585-587
13. Wang Y.M., Yuan B., and Ma M.X. Quantity analysis of blood plasma endothelin and cerebrocuprein of patients with vascular dementia. China Spaceflight Med. Mag. 4 (2002) 41-42
14. Xu K. Neurobiology Program (2000), Science and Technology Press, Beijing p. 365
15. Zhang J.Z., and Ji Z.F. Rational Use of Psychotropic Drugs (2002), People's Health Press, Beijing pp. 130-131
16. Zhang X.R., Zhang Y., Ye L., et al. The effect of the rule for reinforcing kidney and spleen, nourishing blood and accelerating the circulation of blood on the neurobiochemistry chemistry in brain and ultramicrostructure of hippocampus in subacute aging rats. Chin. J. Gerontol. 26 (2006) 804-806
17. Zhou W., and Yu B.R. Dynamic observation of blood plasma endothelin and relevant peptide of calcitonin gene of patients with cerebral infarct. Mag. Apopl. Nerv. Dis. 13 (1996) 145-147